Identification and characterization of persistent human erythrovirus infection in blood donor samples.
about
Human Parvovirus B19 and blood product safety: a tale of twenty years of improvementsParvovirus transmission by blood products - a cause for concern?Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control studyGenetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.Advances in human B19 erythrovirus biologyCharacterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptomsReactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemicBioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissueParvovirus B19 - Revised.Human erythrovirus B19 and blood transfusion - an update.Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patientsDetection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.Bones hold the key to DNA virus history and epidemiology.Human immunodeficiency virus/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China.Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infectionsThe effects of co-infection with human parvovirus B19 and Plasmodium falciparum on type and degree of anaemia in Ghanaian childrenWithin-host genetic diversity of endemic and emerging parvoviruses of dogs and catsVirus detection and semiquantitation in explanted heart tissues of idiopathic dilated cardiomyopathy adult patients by use of PCR coupled with mass spectrometry analysis.Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet ConcentrateSeroprevalence of human parvovirus B19 in healthy blood donors.A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion.Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3bMolecular characterization of human parvovirus B19 genotypes 2 and 3.Virological diagnosis of central nervous system infections by use of PCR coupled with mass spectrometry analysis of cerebrospinal fluid samples.Simian parvoviruses: biology and implications for researchFrequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals.Human Parvoviruses.Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins.Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses.Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.Genotype 1 of human parvovirus B19 in clinical cases.Human parvovirus B19 surveillance in patients with rash and fever from Belarus.Parvovirus B19 infections in state of Rio de Janeiro, Brazil: 526 sera analyzed by IgM-enzyme-linked immunosorbent assay and polymerase chain reaction.Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.Parvovirus infection: an immunohistochemical study using fetal and placental tissue.SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA
P2860
Q28087734-250389F2-00D0-4290-9413-13314D678DC0Q30571511-72700244-6C61-42EC-8D94-E9E4EB8A46F3Q33431762-16204DE1-5D63-4F75-B8D5-0D159F962312Q33548917-08C65BF3-94F9-4A18-804B-05117BEFFD7CQ33614182-21C8DB01-7805-45D0-90B0-7B7E8850ECCAQ34120900-B67DFD8B-6BD5-43F4-8532-D3C9745A1F31Q34120947-E862C368-AC68-4785-B536-7D783935AAD9Q34124006-2A84B07E-17BC-4337-B99C-316C86BD7FF1Q34430679-F64CC21F-0CC9-4FDB-8416-0945D88C4254Q34569072-60580E38-D46D-4990-9B55-B492C6F19F3CQ34624583-56AF3D6E-A9EA-4B21-BA53-24FB77B535CFQ34625443-57D8C0AD-FE7A-49DA-ABC5-B3FB8955AC65Q34660084-C5221584-149D-44BA-B9B2-43FE5855CD2EQ34941558-E7BCFCDB-7DEC-4036-98D4-A08E0622B70EQ35781991-9245DB01-A825-4767-A314-2CF18E485160Q36324310-ADEF8405-18AF-4C84-A6A0-30A89B27F4D7Q36393530-3E683792-1DBC-4889-B08F-98BEE38B293CQ36747943-17CB5EC9-EB17-424C-9DD9-20614F58F3F5Q36768164-D7E03F1C-DEA5-4209-9798-4B233A9CEED7Q36949820-85BA250B-42F9-47ED-A798-5A136DABA654Q36971127-9691DC35-8A9F-4839-AF2C-470F49B5428FQ37045818-88703E82-B7FA-4A1B-9193-CA1FB6BFAF57Q37391153-46A6B0A3-2C84-435B-9876-1D7527A128AAQ37398336-FD71E648-0FB5-4DD4-808F-817998B62C51Q37410574-06BEFD9F-92BC-452A-AB48-9AC3FC35C675Q37465311-3B3443FE-63E1-4655-89D6-808C046FB812Q37546751-08209922-9ED7-4BFC-8C3F-6E0ED613B2C7Q37606000-40CDBC07-F89E-4A59-B9D2-84FDA6C12358Q38432271-0397C35B-87BF-48C9-953C-E7287EE8539AQ38996997-043F0CFE-0A79-42FB-9EC6-87926E2EB842Q40075393-065ACB71-0C41-44E8-B82E-FBCCC80E5988Q40078515-5894BBA0-29B4-4153-B83C-04F96D1964D3Q40132449-8A417348-29FE-4693-862C-8127CAA217ADQ40207807-8D747142-433D-4723-B7C7-E816397406A3Q40290451-660FAF06-93A1-426A-B727-6319180C7698Q40487398-108A6880-397A-4175-9B02-D16849ECBAF0Q41294587-905DC19D-1D25-4B10-96DD-9FC2E42041D8Q41430956-C9E7E50B-8593-431E-96FA-635A28CE2F45Q41681959-1D658E7E-A135-4507-A77D-7383309715C6Q41862044-5B37213E-16BE-452F-988B-89E0D8D3A4B1
P2860
Identification and characterization of persistent human erythrovirus infection in blood donor samples.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Identification and characteriz ...... ection in blood donor samples.
@en
Identification and characteriz ...... ection in blood donor samples.
@nl
type
label
Identification and characteriz ...... ection in blood donor samples.
@en
Identification and characteriz ...... ection in blood donor samples.
@nl
prefLabel
Identification and characteriz ...... ection in blood donor samples.
@en
Identification and characteriz ...... ection in blood donor samples.
@nl
P2093
P2860
P1433
P1476
Identification and characteriz ...... ection in blood donor samples.
@en
P2093
Armen Parsyan
Daniel Candotti
Jean-Pierre Allain
Nermin Etiz
P2860
P304
12169-12178
P356
10.1128/JVI.78.22.12169-12178.2004
P407
P577
2004-11-01T00:00:00Z